Brief: Angle Plc Announces Results From DNA Molecular Analysis Of Cancer Patient Blood Samples

Cellbxhealth

04/01/2024 07:35

Jan 4 (Reuters) - Angle PLC  AGLE.L :
    * BREAKTHROUGH CLINICAL RESULTS
    * NEW DNA SAMPLE-TO-ANSWER MOLECULAR SOLUTION COMBINING CTC
AND
CTDNA ANALYSIS IS EXPECTED TO BE A DRIVER OF PRODUCT AND PHARMA
SERVICES SALES
    * ANNOUNCES BREAKTHROUGH RESULTS FROM DNA MOLECULAR ANALYSIS
OF
CANCER PATIENT BLOOD SAMPLES
    * RESULTS PROVIDE A UNIQUE INSIGHT INTO PROGRESSION OF EACH
PATIENT'S CANCER AND HOW THIS MAY BE TREATED

Source text for Eikon:  ID:nRSD5877Ya 
Further company coverage:  AGLE.L 

 ((Reuters.Briefs@thomsonreuters.com;;))